Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Sphere Fluidics
Sphere Fluidics
Activities:
Manufacturing
Analysis
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
Therapeutic: ensifentrine for chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) comes in various guises, including chronic bronchitis and emphysema; and, although incurable, the symptoms can be managed with...
Merck’s clesrovimab meets all primary endpoints in Phase IIb/III trial for RSV in infants
A teaser of the Phase IIb/III trial released by Merck indicates that clesrovimab can reduce the need to medically attend lower respiratory infections caused by RSV in infants
Bringing biotech to the Baltics: the rise of Lithuania
Lithuania’s biotechnology competencies lie in cell and gene therapies, enzymes and the wider pharmaceutical industry, offering companies a rich pool of talent in a...
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Analysis
Sphere Fluidics launches Cyto-CellectPLUS to accelerate cell line development workflows
Next-generation assay provides a rapid and cost-effective solution to quantify IgG production in single cells
Analysis
Sphere Fluidics appoints Curtis Nicholson as Director of Sales: EMEA
Curtis will lead the expansion of the company's sales and customer support activities
Analysis
Sphere Fluidics appoints Dale Levitzke as CEO
Dale Levitzke joins as Dr Frank F. Craig, current CEO and co-founder, announces his retirement
Analysis
Edward Rayner appointed as as Non-Executive Director of Sphere Fluidics
Ed’s appointment will strengthen the company’s strategic vision as it progresses ambitious plans for future growth and commercial success
Manufacturing
Sphere Fluidics appoints Dr Graeme Daniels as Vice President of Sales and Marketing
Appointment to senior leadership team strengthens the Company’s plans for continued growth to advance its commercial ambitions
Manufacturing
Sphere Fluidics' platform chosen by Biosyntia for screening capabilities
Platform selected to accelerate precision fermentation workflows, to support more sustainable and cost-effective manufacturing for active ingredients in vitamins and bioactives
Manufacturing
Sphere Fluidics aligns with global commercial growth strategy
The company has seen a period of significant expansion over the last twelve months, including a series of new appointments within the senior leadership team
Subscribe now